Literature DB >> 5936177

Turnover of 131-I-labelled fibrinogen in man. Studies in normal subjects, in congenital coagulation factor deficiency states, in liver cirrhosis, in polycythemia vera and in epidermolysis bullosa.

B Blombäck, L A Carlson, S Franzén, E Zetterqvist.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5936177     DOI: 10.1111/j.0954-6820.1966.tb07973.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


× No keyword cloud information.
  8 in total

1.  Haemostatic defects in polycythaemia vera.

Authors:  N E Stathakis; A G Papayannis; G Arapakis; C Gardikas
Journal:  Blut       Date:  1974-08

2.  [Autologous 131J-tagged human fibrinogen for early detection of venous thrombosis (preparation, biological and in vivo properties) (author's transl)].

Authors:  T Wuppermann; K Sippel; H Dahlgrün
Journal:  Klin Wochenschr       Date:  1978-05-01

3.  The fibrinolytic enzyme system in hepatic cirrhosis and malignant metastases.

Authors:  D Ogston; N B Bennett; C M Ogston
Journal:  J Clin Pathol       Date:  1971-12       Impact factor: 3.411

4.  The significance of variations in immunoreactive and clottable fibrinogen in health and following thrombosis.

Authors:  P Wolf; G W Farrell; K W Walton
Journal:  J Clin Pathol       Date:  1972-01       Impact factor: 3.411

5.  Metabolism of fibrinogen in cirrhosis of the liver.

Authors:  G N Tytgat; D Collen; M Verstraete
Journal:  J Clin Invest       Date:  1971-08       Impact factor: 14.808

6.  Studies on vitamin E and selenium deficiency in young pigs. IV. Effect on coagulation system.

Authors:  M Fontaine; V E Valli; L G Young
Journal:  Can J Comp Med       Date:  1977-01

7.  Studies of the metabolism and distribution of fibrinogen in patients with hemophilia A.

Authors:  Y Takeda; A Y Chen
Journal:  J Clin Invest       Date:  1967-12       Impact factor: 14.808

8.  Time course of haemostatic effects of fibrinogen concentrate administration in aortic surgery.

Authors:  C Solomon; C Hagl; N Rahe-Meyer
Journal:  Br J Anaesth       Date:  2013-02-06       Impact factor: 9.166

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.